Literature DB >> 27119139

Translating Science into Survival: Report on the Inaugural International Cancer Immunotherapy Conference.

Vanessa M Hubbard-Lucey, Matthew J Tontonoz.   

Abstract

The inaugural International Cancer Immunotherapy Conference, cohosted by the Cancer Research Institute (CRI), the American Association for Cancer Research (AACR), the Association for Cancer Immunotherapy (CIMT), and the European Academy of Tumor Immunology (EATI), was held in New York City on September 16–19, 2015. The conference brought together nearly 1,400 scientists, clinicians, regulators, patient advocates, and other stakeholders to discuss the latest scientific developments in cancer immunology and immunotherapy, as well as the regulatory hurdles facing new drug development. This conference report summarizes the main themes that emerged during the 4-day meeting.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27119139     DOI: 10.1158/2326-6066.cir-15-0279

Source DB:  PubMed          Journal:  Cancer Immunol Res        ISSN: 2326-6066            Impact factor:   11.151


  1 in total

1.  PD-L1 Status in Refractory Lymphomas.

Authors:  Semir Vranic; Nilanjan Ghosh; Jeffery Kimbrough; Nurija Bilalovic; Ryan Bender; David Arguello; Yvonne Veloso; Aida Dizdarevic; Zoran Gatalica
Journal:  PLoS One       Date:  2016-11-18       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.